Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yury Ragulin"'
Publikováno v:
Thoracic Surgery.
Background: The development of pulmonary metastases is associated with poor survival of cancer patients. Metastasectomy reveals potential survival benefits for some patients with pulmonary lesions. Aim: To assess a long-term survival of patients who
Autor:
Marat G. Gordiev, Viktor Prikhod'ko, Sergei Andreev, Vera Karaseva, Liudmila Gurina, Valeriy Breder, Konstantin Laktionov, Yury Ragulin, Tatiana Kekeeva, Aleksandr Ageev, I. A. Demidova, Maxim L. Filipenko, Viktor Khaylenko, Aleksandr Filippov, Vadim Kozlov, Dina Sakaeva, Evgenii Imianitov, Galina Statsenko, Pavel Grigoriev, Evgenia Ivanova
Publikováno v:
Journal of Clinical Oncology. 37:e13109-e13109
e13109 Background: There is a little information of correlation between EGFRm rate in cytology and plasma samples in Russian NSCLC population. The interim analysis of the study aimed to evaluate the prevalence and types of EGFR mutations in paired cy
Autor:
Gamzat G. Aminov, Yury S. Mardynsky, Yury Ragulin, Igor I. Kotuchov, Konstantin Gordon, Igor Gulidov
Publikováno v:
Advanced Materials Research. 1084:464-466
We present long-term treatment outcomes of 201 patients with breast carcinoma who received a radical course of radiation therapy as a component of multimodality treatment. Ninety five of them received mixed photon-neutron therapy (the study group), a
Autor:
Vladimir Usachev, Evgeny Smolenov, Yury Ragulin, Aleksey Starodubtcev, Aleksander Popov, Aleksander Kurilchik, Ivan Zaborskiy
Publikováno v:
Journal of Thoracic Oncology. 12:S1029-S1030
Publikováno v:
11.1 Lung Cancer.
Results of the treatment of inoperable non-small cell lung cancer are unsatisfactory. This study presents the results of chemoradiation treatment with accelerated hyperfractionated regime with uneven crushing daily dose in these patients. Methods: Th
Autor:
Olga Izmestyeva, Vladimir Vapnyar, Leonid Zhavoronkov, Natalia Severskaya, Yury Ragulin, Victor Derbugov, Marina Poluektova
Publikováno v:
Journal of Thoracic Oncology. 12:S829
Autor:
Igor Bondarenko, Vikram K. Chand, Bushi Wang, M. Cobo, Yury Ragulin, Filippo de Marinis, Joo Hang Kim, Francesco Grossi, Martin Schuler, Edith Gracien, James Chih-Hsin Yang
Publikováno v:
ResearcherID
7558 Background: Patients with squamous NSCLC have limited treatment options. For those deriving benefit from EGFR TKIs, it is unclear whether sustained ErbB family blockade offers benefit upon progression. We evaluated afatinib, an irreversible bloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0fc6b8c6e03e7d0c79df33d3b2c3c9
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000318009804320&KeyUID=WOS:000318009804320
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000318009804320&KeyUID=WOS:000318009804320